Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection

Madison Cristinziano, Elena Shashkina, Liang Chen, Jaime Xiao, Melissa B. Miller, Christina T. Doligalski, Raymond D. Coakley, Leonard J. Lobo, Brent Footer, Luther A. Bartelt, Lawrence Abad, Daniel A. Russell, Rebecca A. Garlena, Michael J. Lauer, Maggie Viland, Ari Kaganovsky, Emily Mowry, Deborah Jacobs‐Sera, David van Duin, Barry N. Kreiswirth, Graham F. Hatfull, Anne Friedland

Nature Communications · 2024

Read source ↗ All evidence

Summary

Nontuberculous mycobacterium (NTM) infections are challenging to manage and are frequently non-responsive to aggressive but poorly-tolerated antibiotic therapies. Immunosuppressed lung transplant patients are susceptible to NTM infections and poor patient outcomes are common. Bacteriophages present an alternative treatment option and are associated with favorable clinical outcomes. Similarly, dual beta-lactam combinations show promise in vitro, but clinical use is sparse. We report here a patient with an uncontrolled Mycobacterium abscessus infection following a bilateral lung transplant and failed antibiotic therapy. Both smooth and rough colony morphotype strains were initially present, but treatment with two phages that kill the rough strain - including epigenetic-modification to overco

Subject
Other / interdisciplinary
Source type
Peer-reviewed study
System type
Other
DOI
10.1038/s41467-024-54666-4
Catalogue ID
SNmojj1mz0-uyxgwt
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.